Sort
146,196 grants matching “diabetes”
Disease-modifying drugs for T2D through targeting the Unfolded Protein Response
$667,957Feroz R Papa · University Of California, San Francisco · R01 · FY2025 · DK
Loneliness in Aging with Schizophrenia
$667,956Barton W. Palmer · University Of California, San Diego · R01 · FY2024 · MH
Autoimmunity Center of Excellence - Rochester
$667,941Ignacio E. Sanz · University Of Rochester · U19 · FY2011 · AI
Genetics of adipose cell-type expression and cardiometabolic traits
$667,930Paivi Pajukanta · University Of California Los Angeles · R01 · FY2022 · DK
Targeting ADAM17 activity for correction of vascular insulin resistance in type 2 diabetes
$667,915Luis A Martinez-Lemus · University Of Missouri-Columbia · R01 · FY2024 · HL
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy
$667,911Owen T. Carmichael · Lsu Pennington Biomedical Research Ctr · R01 · FY2020 · AG
Socioecological Determinants of Immunoepigenetic Signatures of Diabetes Risk in Indigenous Communities
$667,856Alika K Maunakea · University Of Hawaii At Manoa · R01 · FY2023 · MD
Combining Policy and Implementation Science to Optimize Clinical Practice
$667,853Dana Alexa Telem · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
$667,853Donald A. McClain · Wake Forest University Health Sciences · R01 · FY2021 · DK
A Team-Based and Technology Driven Adherence Intervention to Improve Chronic Disease Outcomes
$667,835Joann M Sperl-Hillen · Healthpartners Institute · R01 · FY2022 · HL
Novel Isoform-specific Targeting of PKA
$667,833Susan S Taylor · University Of California, San Diego · P01 · FY2016 · DK
Neurocognition in youth with prediabetes
$667,822Dana M Small · Yale University · R01 · FY2021 · DK
Targeted Genetic Analysis of T2D and Quantitative Traits
$667,816Karen L Mohlke · Univ Of North Carolina Chapel Hill · R01 · FY2020 · DK
MULTICENTERED STUDY OF STROKE GENETICS
$667,814Mayo Clinic Coll Of Med, Jacksonville · R01 · FY2001 · NS
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$667,798Warren J Leonard · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Mode of action of a new Tat HIV-1 inhibitor
$667,765Susana T Valente · Scripps Florida · R01 · FY2012 · AI
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$667,763Donald F Hunt · University Of Virginia · R37 · FY2008 · AI
Closed-Loop Effectiveness and Ambulatory Regimens (CLEAR)
$667,735Stuart A Weinzimer · Yale University · R01 · FY2012 · DK
Targeted Lymphoablation as an alternative to HSCT to cure T1D
$667,733Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2022 · DK
Improving Diabetes Outcomes: The Diabetes Support Project
$667,673Paula Mary Trief · Upstate Medical University · R18 · FY2011 · DK
Endoderm Induction and Pancreatic Specification from ES*
$667,660Gordon M Keller · University Health Network · U01 · FY2007 · DK
Project Title: PROSPECT: Puerto Rico Observational Study of Psychosocial, Environmental, and Chronic Disease Trends
$667,658Josiemer Mattei · Harvard School Of Public Health · R01 · FY2018 · HL
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients
$667,628Heidi M. Crane · University Of Washington · R01 · FY2025 · HL
Enhancing Support for Women w/Type 2 Diabetes: Follow-Up
$667,624Deborah J Toobert · Oregon Research Institute · R01 · FY2007 · HL
Health Impacts of City-Wide Zero-Fare Bus Transit: A Natural Experiment
$667,617Jannette Yvonne Berkley-Patton · University Of Missouri Kansas City · R01 · FY2023 · DK